📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sagimet Biosciences

1.1 - Company Overview

Sagimet Biosciences Logo

Sagimet Biosciences

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel therapeutics targeting FASN, including Denifanstat, an oral, once-daily selective FASN inhibitor in development for MASH, acne, and certain cancers, and TVB-3567, a pipeline FASN inhibitor planned for U.S. clinical development for acne.

Products and services

  • Denifanstat: An oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne, and certain cancers
  • Novel Therapeutics Development: A biotechnology effort that focuses on developing novel therapeutics to treat important diseases, including denifanstat and TVB-3567
  • TVB-3567: A pipeline product candidate showing potent FASN inhibitory activity, planned for clinical development in the U.S. for the treatment of acne.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sagimet Biosciences

Kymab Logo

Kymab

HQ: United Kingdom Website
  • Description: Provider of fully human monoclonal antibody therapeutics focused on immune-mediated diseases and immuno-oncology, developed using proprietary, integrated IntelliSelect platforms. IntelliSelect Transgenic platforms contain a full diversity of human antibodies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kymab company profile →
Bristol Myers Squibb Logo

Bristol Myers Squibb

HQ: United States Website
  • Description: Provider of pharmaceuticals, engaging in the discovery, development, licensing, manufacturing, marketing, distribution and sale of therapies, including cancer immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab); anticoagulant Eliquis (apixaban); oncology treatments Revlimid (lenalidomide) and Sprycel (dasatinib); and autoimmune therapy Orencia (abatacept).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bristol Myers Squibb company profile →
Coley Pharmaceutical Logo

Coley Pharmaceutical

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics and drug candidates that direct the human immune system to fight cancers, asthma, allergy, and autoimmune disorders, and to enhance the effectiveness of vaccines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Coley Pharmaceutical company profile →
Matrx Pharmaceuticals Logo

Matrx Pharmaceuticals

HQ: Poland Website
  • Description: Provider of pharmaceuticals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Matrx Pharmaceuticals company profile →
Chiva Pharmaceuticals Logo

Chiva Pharmaceuticals

HQ: United States Website
  • Description: Provider of global pharmaceutical solutions focused on bringing the best standard of care to the Chinese market and making drugs developed in China available worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Chiva Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sagimet Biosciences

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sagimet Biosciences

2.2 - Growth funds investing in similar companies to Sagimet Biosciences

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sagimet Biosciences

4.2 - Public trading comparable groups for Sagimet Biosciences

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sagimet Biosciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sagimet Biosciences

What does Sagimet Biosciences do?

Sagimet Biosciences is a provider of novel therapeutics targeting FASN, including Denifanstat, an oral, once-daily selective FASN inhibitor in development for MASH, acne, and certain cancers, and TVB-3567, a pipeline FASN inhibitor planned for U.S. clinical development for acne.

Who are Sagimet Biosciences's competitors?

Sagimet Biosciences's competitors and similar companies include Kymab, Bristol Myers Squibb, Coley Pharmaceutical, Matrx Pharmaceuticals, and Chiva Pharmaceuticals.

Where is Sagimet Biosciences headquartered?

Sagimet Biosciences is headquartered in United States.

How many employees does Sagimet Biosciences have?

Sagimet Biosciences has 1,000 employees 🔒.

When was Sagimet Biosciences founded?

Sagimet Biosciences was founded in 2010 🔒.

What sector and industry vertical is Sagimet Biosciences in?

Sagimet Biosciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sagimet Biosciences

Who are the top strategic acquirers in Sagimet Biosciences's sector and industry

Top strategic M&A buyers and acquirers in Sagimet Biosciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sagimet Biosciences?

Top strategic M&A buyers groups and sectors for Sagimet Biosciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sagimet Biosciences's sector and industry vertical

Which are the top PE firms investing in Sagimet Biosciences's sector and industry vertical?

Top PE firms investing in Sagimet Biosciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sagimet Biosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sagimet Biosciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sagimet Biosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sagimet Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sagimet Biosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sagimet Biosciences?

The key public trading comparables and valuation benchmarks for Sagimet Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sagimet Biosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sagimet Biosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sagimet Biosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sagimet Biosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sagimet Biosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in Sagimet Biosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sagimet Biosciences